Laos — HIV Funding Impacts

21,000

People living with HIV, 2024

WHO Global Health Observatory

64.0%

On antiretroviral treatment, 2024

WHO Global Health Observatory

$486k

United States HIV disbursements, 2026

ForeignAssistance.gov

$8.3m

External HIV financing, all donors, 2024

OECD Creditor Reporting System

External HIV financing

OECD CRS · ForeignAssistance.gov

All donors
United States, OECD record
The Global Fund
United States, self-reported

Year	All donors	United States, OECD record	The Global Fund	United States, self-reported
2002	$571k	—	—	—
2003	$1.4m	$175k	$678k	—
2004	$1.7m	$1.0m	$420k	$1.0m
2005	$4.2m	$800k	$2.2m	$1.0m
2006	$3.1m	$650k	$2.1m	$650k
2007	$3.9m	$6k	$3.1m	—
2008	$4.8m	$934k	$3.0m	$818k
2009	$8.0m	$804k	$6.5m	$752k
2010	$6.4m	$1.4m	$3.1m	$1.2m
2011	$11.0m	$1.0m	$7.8m	$1.2m
2012	$6.0m	$1.1m	$3.6m	$1.3m
2013	$9.2m	$207k	$6.4m	$304k
2014	$7.5m	$249k	$4.7m	$152k
2015	$5.8m	$348	$2.4m	$49k
2016	$5.4m	$91	$3.4m	$91
2017	$4.5m	$4k	$3.1m	$4k
2018	$2.1m	—	$2.0m	—
2019	$1.9m	$74k	$1.8m	—
2020	$5.8m	$520k	$4.0m	$427k
2021	$8.6m	$1.1m	$7.0m	$1.2m
2022	$7.0m	$1.3m	$5.6m	$1.7m
2023	$9.4m	$1.9m	$7.3m	$1.8m
2024	$8.3m	$1.9m	$6.4m	$1.8m
2025	—	—	—	$1.9m
2026	—	—	—	$486k°

25 rows, as drawn above. A value marked ° comes from a reporting period that is still open or that the source marks as incomplete. Values are rounded for reading; the download carries them unrounded.

Disbursements reported for this country. The OECD record and the United States self-reported record are drawn separately; they cover the same flow but are filed on different calendars. The point at 2026 is drawn from a reporting period that is still open or that the source marks as incomplete, and is shown as an open ring. Do not read it as a fall.

People living with HIV and people on treatment

UNAIDS AIDSinfo

People living with HIV
People on treatment

Year	People living with HIV	People living with HIV (lower)	People living with HIV (upper)	People on treatment
2000	2,300	2,000	2,500	—
2001	2,900	2,600	3,200	—
2002	3,600	3,200	4,000	—
2003	4,200	3,800	4,700	—
2004	4,900	4,400	5,400	—
2005	5,500	5,000	6,100	—
2006	6,300	5,600	6,900	—
2007	7,000	6,300	7,700	—
2008	7,800	7,000	8,600	—
2009	8,600	7,800	9,400	—
2010	9,400	8,500	10,000	1,700
2011	10,000	9,200	11,000	2,000
2012	11,000	9,900	12,000	2,400
2013	12,000	11,000	13,000	2,800
2014	12,000	11,000	14,000	3,300
2015	13,000	12,000	14,000	3,900
2016	14,000	13,000	15,000	4,600
2017	15,000	13,000	16,000	5,600
2018	16,000	14,000	17,000	6,500
2019	17,000	15,000	18,000	7,300
2020	17,000	16,000	19,000	8,200
2021	18,000	16,000	20,000	8,900
2022	19,000	17,000	21,000	10,000
2023	20,000	18,000	22,000	12,000
2024	21,000	19,000	23,000	13,000

25 rows, as drawn above. Values are rounded for reading; the download carries them unrounded.

Modelled estimates. The shaded band is the published uncertainty interval around the number of people living with HIV; a point estimate on its own would overstate what is known.

The treatment cascade

UNAIDS AIDSinfo

Know their status
On treatment
Virally suppressed

Year	Know their status	On treatment	Virally suppressed
2010	20.0%	18.0%	—
2011	23.0%	20.0%	—
2012	24.0%	22.0%	—
2013	26.0%	24.0%	—
2014	30.0%	27.0%	—
2015	34.0%	29.0%	—
2016	40.0%	33.0%	—
2017	46.0%	38.0%	—
2018	50.0%	41.0%	40.0%
2019	55.0%	44.0%	43.0%
2020	60.0%	47.0%	45.0%
2021	65.0%	49.0%	49.0%
2022	70.0%	54.0%	53.0%
2023	76.0%	59.0%	58.0%
2024	82.0%	64.0%	63.0%

15 rows, as drawn above. Values are rounded for reading; the download carries them unrounded.

Each figure is a share of all people living with HIV, so the three lines are on one denominator and can be read against each other. Suppression here is community viral suppression, not the narrower third target.

Data-quality flags on Laos

Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS), 2020 (PEPFAR Panorama Spotlight) — discontinuity vs 2019: 47 -> 239. Likely a reporting-scope/partner-attribution change — NOT comparable year-on-year; inspect partner-level detail before using in trend analysis.

Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS), 2021 (PEPFAR Panorama Spotlight) — discontinuity vs 2020: 239 -> 1,596. Likely a reporting-scope/partner-attribution change — NOT comparable year-on-year; inspect partner-level detail before using in trend analysis.

Number of people on ART (PEPFAR MER TX_CURR), 2019 (PEPFAR Panorama Spotlight) — discontinuity vs 2018: 5,063 -> 755. Likely a reporting-scope/partner-attribution change — NOT comparable year-on-year; inspect partner-level detail before using in trend analysis.

Number of people on ART (PEPFAR MER TX_CURR), 2020 (PEPFAR Panorama Spotlight) — discontinuity vs 2019: 755 -> 7,575. Likely a reporting-scope/partner-attribution change — NOT comparable year-on-year; inspect partner-level detail before using in trend analysis.

Sources behind these figures

436 rows

Source	Type	Rows	Indicators	Years	Read from	Retrieved
UNAIDS AIDSinfo	Modelled estimate	184	12	2000–2024	aidsinfo.unaids.org	2026-07-20
WHO Global Health Observatory	Modelled estimate	99	4	2000–2024	ghoapi.azureedge.net	2026-07-20
OECD Creditor Reporting System	Expenditure account	66	3	2002–2024	sdmx.oecd.org	2026-07-20
World Bank Open Data	Modelled estimate	51	2	2000–2025	api.worldbank.org	2026-07-20
ForeignAssistance.gov	Expenditure account	20	1	2004–2026	foreignassistance.gov	2026-07-20
PEPFAR Panorama Spotlight	Programme record	16	2	2018–2025	data.pepfar.gov	2026-07-20

Indicators held

17 of 31

Indicator	Domain	Unit	Rows	Years	Sources	Most recent value
Country-reported HIV expenditure, all sources	Financing	USD	8	2016–2024	UNAIDS AIDSinfo	$3.8m (2024)
External HIV financing (all donors, ODA)	Financing	USD	23	2002–2024	OECD Creditor Reporting System	$8.3m (2024)
External HIV financing from the United States (ODA)	Financing	USD	41	2003–2026	ForeignAssistance.gov, OECD Creditor Reporting System	$486k (2026)
Global Fund HIV disbursements to the country	Financing	USD	22	2003–2024	OECD Creditor Reporting System	$6.4m (2024)
% of ALL PLHIV who are virally suppressed	Treatment cascade	percent	7	2018–2024	UNAIDS AIDSinfo	63.0% (2024)
% of PLHIV on ART (2nd 95, PLHIV base)	Treatment cascade	percent	39	2000–2024	UNAIDS AIDSinfo, WHO Global Health Observatory	64.0% (2024)
% of PLHIV who know their status (1st 95)	Treatment cascade	percent	17	2010–2024	UNAIDS AIDSinfo	62.3% (2024)
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS)	Treatment cascade	count	8	2018–2025	PEPFAR Panorama Spotlight	417 (2025)
Number of people on ART (PEPFAR MER TX_CURR)	Treatment cascade	count	23	2010–2025	PEPFAR Panorama Spotlight, UNAIDS AIDSinfo	15,290 (2025)
PMTCT ART coverage among pregnant women with HIV	Treatment cascade	percent	15	2010–2024	UNAIDS AIDSinfo	68.0% (2024)
AIDS-related deaths (all ages)	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Health Observatory	500 (2024)
HIV prevalence among a key population	Epidemic estimates	percent	2	2024	UNAIDS AIDSinfo	1.8% (2024)
HIV prevalence, ages 15-49	Epidemic estimates	percent	50	2000–2024	UNAIDS AIDSinfo, World Bank Open Data	0.4% (2024)
New HIV infections (all ages)	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Health Observatory	1,300 (2024)
People living with HIV (all ages)	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Health Observatory	21,000 (2024)
People receiving PrEP	Prevention and outreach	count	5	2020–2024	UNAIDS AIDSinfo	1,700 (2024)
Total population	Population denominators	count	26	2000–2025	World Bank Open Data	7,873,046 (2025)

Every row shown here is in the panel download, with its source URL and retrieval date attached. See Data.